Yasser Ged: h-index, Total Citations, and Citation Map
Yasser Ged's h-index is 19 (32 i10-index, 2,132+ total citations across 132+ publications) according to Google Scholar as of May 2026. Yasser Ged is affiliated with Johns Hopkins University.
Yasser Ged is a researcher affiliated with Johns Hopkins University, specializing in Genitourinary Cancer, Kidney cancer, testicular cancer. Their work has been cited 2,132 times. This profile visualizes their global influence, highlighting strong citation networks in China.
Yasser Ged's Citation Metrics
Bibliometric impact based on 132 indexed publications. Of these, 19 are original research articles — the rest are literature highlights, conference abstracts or theses.
- H-Index
- 19
- i10-Index
- 32
- Total Citations
- 2,132
- Citing Countries
- 49
As of May 2026.
Yasser Ged has an h-index of 19 and 2,132 total citations across 132 publications, with research cited by institutions in 49 countries.
Download Exports (PNG, CSV, Poster)
Free Viewing Yasser Ged's citation map is always free. Pay once to download poster, PNG, and CSV files for offline use or your visa packet.
Global Impact Map
Visualizing the geographic distribution of institutions that have cited your work.
Starting…
Pins will appear here as institutions are resolved — no need to refresh.
Top Cited Works
Tip: clickto hide a row from the map
Kidney cancer, version 3.2022, NCCN clinical practice guidelines in oncology
2022727
Top Citing Countries
Top Citing Institutions
Visa Evidence Package
Views and exports tuned for EB-1A, O-1A, and EB-2 NIW petitions. Sustained acclaim, geographic reach, and independent-citation filtering are the strongest evidence categories immigration adjudicators look for.
Significant Contributions
Auto-detected research lines — a seminal paper and the follow-up work building on it. Review and edit before using in a petition. Each Free PDF opens in a new tab — EB-1A organises this into the structure USCIS applies to Criterion 5 of 8 CFR § 204.5(h)(3)(v); EB-1B re-frames it under § 204.5(i)(3) (outstanding researcher); NIW presents it under prong 2 of Matter of Dhanasar.
873 citing papers could not be classified (no author data) — excluded from the percentages above.
The researcher established foundational clinical guidelines for kidney cancer and extended this framework to address complex translocation renal cell carcinomas through multi-institutional analyses.
The researcher established a foundational framework linking PBAF complex mutations to immunotherapy response, subsequently refining predictive biomarkers for renal cell carcinoma treatment outcomes.
The researcher established that sarcomatoid differentiation dictates clinical outcomes in metastatic chromophobe renal cell carcinoma, a framework subsequently expanded to include high-grade nonsarcomatoid variants and rare extrarenal manifestations.
Citation trend (last 10 years)Click to expand
Citation Trend (Last 10 Years)
Related Guides
Learn how to use citation maps for your research and visa applications.
